Doctors less likely than patients to report toxicity of cancer treatments, study shows

Doctors consistently under-report symptomatic toxicities, such as nausea, associated with anticancer treatments when compared with patients’ reporting, shows a study that looked at data on side effects reported prospectively in three randomised trials.1

“Information about symptomatic toxicities of anticancer treatments is not based on direct reports by patients but rather on reports by clinicians in trials,” explained the researchers, led by Francesco Perrone, from Italy’s National …